FDA/MHRA/Health Canada Symposium: Regulatory perspectives in good clinical practice, bioequivalence and good pharmacovigilance practice June 2 - 4, 2026

https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fdamhrahealth-canada-symposium-regulatory-perspectives-good-clinical-practice-bioequivalence-and?utm_medium=email&utm_source=govdelivery Reminder to Join us for FDA | MHRA | Health Canada Joint Symposium on GCP, BE and GVP Register now to secure your spot at the FDA/UK’s MHRA/Health Canada hybrid symposium, Regulatory Perspectives in Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice, June 2-4, 2026. Join us for a robust discussion with a range of speakers on current and emerging topics of interest related to good clinical practice, bioequivalence and good pharmacovigilance practice. Presentations and panel discussions will examine the implementation of ICH E6(R3) and the cultural shift from compliance-driven to quality-focused clinical trial conduct. Sessions will highlight regulatory expectations, emphasizing quality by design and risk-proportionate approaches to optimize trial efficiency, protect participants and ensure reliable results. Regulatory experts from the FDA, MHRA and Health Canada will provide updates related to good clinical practice, bioequivalence and pharmacovigilance as well as guidance, inspections and international harmonization. Visit Regulatory Perspectives in Good Clinical Practice, Bioequivalence and Good Pharmacovigilance Practice for more information. Reminder to Join us for FDA | MHRA | Health Canada Joint Symposium on GCP, BE and GVP https://events.myconferencesuite.com/joint_us-fda_uk-mhra_health_canada_gcp-be-gvp/reg/form/edit?utm_medium=email&utm_source=govdelivery